Science news

USD 1.08 Bn growth opportunity in Energy-Based Aesthetic Devices Market — Driven by increasing demand for aesthetic procedures

NEW YORK, Aug. 19, 2022 /PRNewswire/ -- The "Energy-Based Aesthetic Devices Market by Product and Geography - Forecast and Analysis 2021-2025" report by Technavio...

Anchor Health Properties Named to Inc. 5000's List of the Nation's Fastest Growing Private US Companies for the Second Consecutive Year

CHARLOTTESVILLE, Va., Aug. 19, 2022 /PRNewswire/ -- Inc. magazine announced this week that Anchor Health Properties (Anchor), a national full-service health care real estate...

Local Executive Earns Top Healthcare Management Credential

CHICAGO, Aug. 19, 2022 /PRNewswire/ -- John Hudson Garrett Jr., FACHE, President and Chief Executive Officer, Community Health Associates, Atlanta, Georgia, recently became a...

USD 86.39 million Growth in First Aid Kit Market Size with 65% Contribution from Asia – Technavio

3M Co., Acme United Corp., and Certified Safety Manufacturing Inc. as major participants NEW YORK, Aug. 19, 2022 /PRNewswire/ -- The latest market analysis report titled First...

Biovancia Sounds Alarm on Decreasing Nutritional Value of Food in the US and Offers Solutions

Today, Biovancia warns consumers of the decreasing nutritional value of foods consumed in the US. Biovancia goes on to offer potential solutions to the...

American Rheumatology Network Announces Sarah McClain as Chief Operating Officer

SUMMERVILLE, S.C., Aug. 18, 2022 /PRNewswire/ -- American Rheumatology Network, LLC ("ARN"), has announced the appointment of Sarah McClain as its Chief Operating Officer (COO)...

BayWa r.e. Teams Up with Power Center, a Duracell Authorized Licensee, to Distribute Home Energy and Storage Solutions

SANTA FE, N.M., Aug. 18, 2022 /PRNewswire/ -- Global renewable energy company BayWa r.e. is bringing new options to solar installation partners across the U.S. by...

Calliditas Therapeutics: Interim Report Q2, 2022

STOCKHOLM, Aug. 18, 2022 /PRNewswire/ -- European approval for Kinpeygo® "On May 19th, the European Medicines Agency (EMA) announced that it had adopted a positive opinion...

Innovent Announces First Subject Dosed in Phase 1 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody)

SAN FRANCISCO and SUZHOU, China, Aug. 17, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

Latest articles